CSIMarket
 


Recursion Pharmaceuticals Inc   (RXRX)
Other Ticker:  
 
 

RXRX's Revenue Growth by Quarter and Year

Recursion Pharmaceuticals Inc 's Revenue results by quarter and year




RXRX Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December 10.89 13.68 2.53 0.00
III Quarter September 10.53 13.16 2.53 0.00
II Quarter June 11.02 7.67 2.55 0.00
I Quarter March 12.13 5.33 2.56 0.00
FY   44.57 39.84 10.17 0.00



RXRX Revenue fourth quarter 2023 Y/Y Growth Comment
Recursion Pharmaceuticals Inc reported decline in Revenue in the fourth quarter 2023 by -20.39% to $ 10.89 millions, from the same quarter in 2022.
The contraction in the fourth quarter 2023 Recursion Pharmaceuticals Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 161.03%.

Looking into fourth quarter 2023 results within Biotechnology & Pharmaceuticals industry 2 other companies have achieved higher Revenue growth. While Recursion Pharmaceuticals Inc ' s Revenue fall of -20.39% ranks overall at the positon no. 127 in the fourth quarter 2023.




RXRX Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December -20.39 % 440.71 % - -
III Quarter September -19.98 % 420.16 % - -
II Quarter June 43.68 % 200.78 % - -
I Quarter March 127.58 % 108.2 % - -
FY   11.88 % 291.74 % - -

Financial Statements
Recursion Pharmaceuticals Inc 's fourth quarter 2023 Revenue $ 10.89 millions RXRX's Income Statement
Recursion Pharmaceuticals Inc 's fourth quarter 2022 Revenue $ 13.68 millions Quarterly RXRX's Income Statement
New: More RXRX's historic Revenue Growth >>


RXRX Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December 3.43 % 3.95 % 0 % -
III Quarter September -4.45 % 71.58 % -0.78 % -
II Quarter June -9.15 % 43.9 % -0.39 % -
I Quarter March -11.33 % 110.67 % - -
FY (Year on Year)   11.88 % 291.74 % - -




Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #3
Healthcare Sector #34
Overall #127

Revenue Y/Y Growth Statistics
High Average Low
291.46 % 161.03 % 11.88 %
(Dec 31 2022)  
Revenue fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #3
Healthcare Sector #34
Overall #127
Revenue Y/Y Growth Statistics
High Average Low
291.46 % 161.03 % 11.88 %
(Dec 31 2022)  

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Recursion Pharmaceuticals Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
110.54 % 18.84 % -11.28 %
(Mar 31 2022)  


RXRX's IV. Quarter Q/Q Revenue Comment
Recursion Pharmaceuticals Inc achieved in the IV. Quarter 2023 below company average Revenue growth of 3.43% quarter on quarter, to $ 10.89 millions.

Within Biotechnology & Pharmaceuticals industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Recursion Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 735.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #15
Healthcare Sector #119
Overall #735
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #15
Healthcare Sector #119
Overall #735
Revenue Q/Q Growth Statistics
High Average Low
110.54 % 18.84 % -11.28 %
(Mar 31 2022)  


RXRX's IV. Quarter Q/Q Revenue Comment
Recursion Pharmaceuticals Inc achieved in the IV. Quarter 2023 below company average Revenue growth of 3.43% quarter on quarter, to $ 10.89 millions.

Within Biotechnology & Pharmaceuticals industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Recursion Pharmaceuticals Inc 's Revenue growth quarter on quarter, overall rank is 735.


Recursion Pharmaceuticals Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 44.58 $ 47.36 $ 49.99 $ 46.64 $ 39.84
Y / Y Revenue Growth (TTM) 11.88 % 65.02 % 176.57 % 260.21 % 291.46 %
Year on Year Revenue Growth Overall Ranking # 15 # 68 # 59 # 42 # 21
Seqeuential Revenue Change (TTM) -5.88 % -5.26 % 7.17 % 17.07 % 38.83 %
Seq. Revenue Growth (TTM) Overall Ranking # 127 # 214 # 573 # 377 # 305




Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2023 period, Recursion Pharmaceuticals Inc 's cumulative twelve months Revenue were $ 45 millions, company would post below average annual Revenue growth of 38.83% year on year, if the fiscal year would end at Dec 31 2023.
A slow-down in the Recursion Pharmaceuticals Inc 's Revenue growth from the 10.53% growth in Sep 30 2023.

Among companies within the Healthcare sector 3 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 15, from total ranking in previous quarter at 68.

Revenue TTM Q/Q Growth Statistics
High Average Low
291.46 %
161.03 %
11.88 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 4
Overall # 15

Revenue TTM Y/Y Growth Statistics
High Average Low
291.46 %
161.03 %
11.88 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 34
S&P 500 # 127
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Dec 31 2023 period, Recursion Pharmaceuticals Inc 's cumulative twelve months Revenue were $ 45 millions, company would post below average annual Revenue growth of 11.88% year on year, if the fiscal year would end at Dec 31 2023.
A slow-down in the Recursion Pharmaceuticals Inc 's Revenue growth from the 10.53% growth in Sep 30 2023.

Among companies within the Healthcare sector 3 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 15, from total ranking in previous quarter at 68.

Revenue TTM Q/Q Growth Statistics
High Average Low
291.46 %
161.03 %
11.88 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 3
Healthcare Sector # 4
Overall # 15

Revenue TTM Y/Y Growth Statistics
High Average Low
291.46 %
161.03 %
11.88 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 3
Sector # 34
S&P 500 # 127




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
RXRX's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for RXRX's Competitors
Revenue Growth for Recursion Pharmaceuticals Inc 's Suppliers
Revenue Growth for RXRX's Customers

You may also want to know
RXRX's Annual Growth Rates RXRX's Profitability Ratios RXRX's Asset Turnover Ratio RXRX's Dividend Growth
RXRX's Roe RXRX's Valuation Ratios RXRX's Financial Strength Ratios RXRX's Dividend Payout Ratio
RXRX's Roa RXRX's Inventory Turnover Ratio RXRX's Growth Rates RXRX's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Healthcare Services Group Inc -0.04%$ -0.042 millions
Integra Lifesciences Holdings Corp-0.25%$ -0.247 millions
National Research Corporation-0.37%$ -0.375 millions
The Beauty Health Company-0.63%$ -0.633 millions
3m Company-0.82%$ -0.817 millions
Viatris Inc -1.00%$ -0.998 millions
Quest Diagnostics Inc-1.93%$ -1.929 millions
Koru Medical Systems Inc-2.16%$ -2.161 millions
Envista Holdings Corporation-2.30%$ -2.300 millions
Zynex inc -3.11%$ -3.114 millions
Baxter International Inc -3.55%$ -3.550 millions
Caribou Biosciences Inc -3.63%$ -3.629 millions
Gilead Sciences Inc -3.72%$ -3.722 millions
Lifevantage Corp-3.92%$ -3.921 millions
Avantor Inc -4.02%$ -4.022 millions
Escalon Medical Corp -4.53%$ -4.533 millions
Inovio Pharmaceuticals Inc -4.55%$ -4.553 millions
Optinose Inc -4.76%$ -4.756 millions
Cryoport inc -5.13%$ -5.133 millions
Psychemedics Corporation-5.24%$ -5.243 millions
Hookipa Pharma inc -5.38%$ -5.378 millions
Abbvie inc -5.42%$ -5.423 millions
Hologic Inc-5.69%$ -5.688 millions
Encision Inc -6.08%$ -6.083 millions
Biogen Inc -6.20%$ -6.199 millions
Curis Inc -6.62%$ -6.616 millions
Bio rad Laboratories Inc -6.62%$ -6.621 millions
Predictive Oncology Inc -7.82%$ -7.825 millions
Charles River Laboratories International inc -7.85%$ -7.853 millions
Cara Therapeutics inc -7.88%$ -7.881 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com